Skip to main content
Indian Journal of Critical Care Medicine : Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine logoLink to Indian Journal of Critical Care Medicine : Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine
. 2019 Feb;23(2):104–105. doi: 10.5005/jp-journals-10071-23127

Elizabethkingia Meningoseptica: An Emerging Nosocomial Pathogen Causing Septicemia in Critically Ill Patients

Manoj Kumar Sahu 1,, Uma Balasubramaniam 2, Bipin C 3, Sarvesh Pal Singh 4, Sachin Talwar 5
PMCID: PMC6487604  PMID: 31086457

ABSTRACT

Elizabethkingia meningoseptica (E. meningoseptica), is an opportunistic Gram-negative bacteria, normally found in water and soil, notorious for causing nosocomial infections in extremes of ages and immunocompromised patients. It is now emerging as a serious nosocomial pathogen, intrinsically resistant to several commonly used antibiotics (e.g. beta-lactams, aminoglycosides, carbapenems and colistin etc. and a cause of high mortality in critically ill patients in intensive care units (ICUs).

We report the first case of E. meningoseptica sepsis in a 5 month old child after open heart surgery for transposition of great arteries, initially on extracorporeal membrane oxygenation, then prolonged mechanical ventilation, with various invasive devices, inotropes and exposed to broad spectrum antibiotics in our ICU. The case highlights the potential risk factors responsible for E.meningoseptica sepsis. Its unusual pattern of resistance to many commonly used antibiotics makes this organism difficult to treat.

How to cite this article

Sahu MK, Balasubramaniam U et al. Elizabethkingia Meningoseptica: An Emerging Nosocomial Pathogen Causing Septicemia in Critically Ill Patients. Indian J of Crit Care Med 2019;23(2):104-105.

Keywords: Elezabethkingia meningoseptica, Intensive care unit, Pediatric cardiac surgery, Sepsis

INTRODUCTION

Elizabethkingia meningoseptica (E. meningoseptica) is a non-motile, non-fermentative, oxidase positive, Gram-negative Bacillus described by Elizabeth O. King in 1959 1. It is not known to reside in human hosts, but notorious for causing nosocomial infections (NI) including meningitis, pneumonia and bacteremia in extremes of ages and immunocompromised hosts2.

The organism colonizes sink basins, taps, and become a potential reservoir for NIs in the hospital environment3. Colonization of the contaminated medical devices involving fluids, ventilators, breathing circuits, endotracheal tubes, humidifiers, intravascular devices, etc. have been documented as of serious concern46. This organism is resistant to many commonly used antibiotics (beta-lactams, carbapenems, aminoglycosides, etc.), posing treatment challenges7. Antimicrobial susceptibility data on this pathogen remains limited, with no established breakpoints by the Clinical and Laboratory Standards Institute criteria for minimum inhibitory concentration interpretation8. We report a case of E. meningoseptica septicemia in a pediatric cardiac surgical patient with multiple risk factors eventually leading to poor outcome.

CASE REPORT

A five month female child weighing five kilos with transposition of great arteries, intact ventricular septum with regressed left ventricle underwent elective primary arterial switch operation. She was shifted to the cardiac surgical intensive care unit (CSICU) with open sternum on extracorporeal membrane oxygenation (ECMO) support because of severe left ventricular dysfunction with left ventricular ejection fraction(LVEF) of ~10%, failing to wean off cardiopulmonary bypass (CPB). The child was on intravenous (iv) inotrope (adrenaline 0.05 μg/kg/min, dobutamine 5mcg/kg/min) and vasodilator (nitroglycerine 0.5 μg/kg/min and phenoxybenzamine 0.5 μg/kg/8 hrly) infusions.

The infant was started on combined antibiotics with tazobactum+piperacilin 50mg/kg/iv/6hrly, amikacin15 μg/kg/iv/24 hrly and vancomycin 10 mg/kg/iv/8 hrly. The hemodynamics, urine output were maintained over time as her left ventricular function improved (LVEF 30%). ECMO was weaned off and sternum was closed after 72 hours. Vancomycin was stopped after sternal closure. Echo assessment revealed persisting LV dysfunction and mild mitral regurgitation. The child remained intubated, ventilated and inotropic support was continued alongwith the vasodilators. Enteral feeding was started with mother's milk through nasogastric tube. All the invasive devices like chest drainage tubes, central venous catheter, urinary catheter and pacing wires were maintained with sterile precautions. Her hemogram, and serum biochemistry remained unremarkable till 8th postoperative day (POD). She continued to be on low cardiac outputstate requiring inotropes and could not be weaned off ventilator. She was tracheostomized on POD 9. On POD 10, she developed fever, raised total leucocyte counts (13,700/mm3) with neutrophil predominance(78%), elevated procalcitonin levels (69.19 ng/mL), low platelets (56000/mm 3). Her systolic blood pressure (SBP) and urine output decreased to <40 mm Hg and <0.5 mL/kg, respectively and she required noradrenaline @ 0.1 μg/kg/min. Peritoneal dialysis (PD) was initiated. Blood, urine and endotracheal aspirate samples were sent for culture. Klebsiella pneumoniae was isolated from endotracheal aspirate and treated with colistin 30000 units/kg/8 hrly and imipenem 20 mg/kg/8 hrly from POD 12. However, the child did not improve appreciably. Repeat culture was done on POD 14 isolated E. meningoseptica, which showed resistance to most of the antibiotics including colistin. This was the first occasion we experienced this rare pathogen in our CSICU. We immediately warranted strict asepsis and followed institutional protocol for infection control to curtail spread of infection. Treatment was started with ciprofloxacin 50 mg/ iv/12 hrly and trimethoprim + sulfamethoxazole 15 mg/iv/8hrly. The child showed signs of improvement for a while but worsened again on POD 20 with deteriorated hemodynamics, requiringhigh dose vasopressor support, increased blood lactate and metabolic acidosis, progressed to septic shock with multiorgan failure and succumbed.

DISCUSSION

E. menigoseptica is a rare Gram-negative opportunistic pathogen, known to cause nosocomial infection in susceptible patients with risk factors like prolonged ventilation, multiple invasive devices, PD, ECMO, exposed to multiple higher antibiotics, infected with other multidrug resistant gram negative pathogens and long ICU stay, etc. The organism is known for late onset of infection, 5-50 days post hospitalization9. It is resistant to a broad range of regularly used antimicrobials including polymixins. However, it is susceptible to antibiotics used to treat gram-positive bacteria i.e. rifampicin, ciprofloxacin, vancomycin and trimethoprim-sulfamethoxazole 9. Vancomycin alone or in combination with rifampicin, has in the past been successful in treating E. meningoseptica10, but its efficacy has been questioned by recent studies 11.

In our case, a post cardiotomy infant on prolonged mechanical ventilation developed sepsis. The time from hospital admission to isolation of organism was 16 days. Klebsiella pneumoniae was isolated from respiratory secretions initially and was treated with colistin and imipenem. While the treatment for klebsiella was being followed up with cultures of tracheal secretions, the second sample from respiratory secretions grew E. meningoseptica which was resistant to almost all routine antibiotics including colistin. Sepsis with klebsiella and treatment with colistin both might have acted as selective factors along with the other risk factors like younger age, delayed sternal closure, ECMO, PD catheter, urinary catheter, prolonged mechanical ventilation, invasive lines and chest drains. All these allowed E. meningoseptica to emerge in the environmental vicinity of the patient and cause nosocomial pneumonia in this already immuncompromised infant.

A recent case series by Govindaswamy et al. reported 12 days (10-25 days) of median time from admission to isolation of E. meningoseptica. All their patients had a history of recent hospitalization, at the time of sepsis, they were on mechanical ventilation in ICU. All cases received 2 or more antibiotics which included colistin and carbapenems. All isolates were resistant to commonly used antibiotics. Mortality rate was high (75%) in their study12. Our patient had findings similar to the above study.

E. meningoseptica has unusual resistance patterns and mechanisms. The reappearance of septic shock was probably attributed to this organism. The child was already infected with Klebsiella, probably it increased the susceptibility of this child to E. meningoseptica sepsis and unusually the child never responded to the treatment and succumbed to septic shock.

In view of its multidrug-resistant nature, its propensity to infect infants, as in our case, and to spread in the hospital environment, its prompt diagnosis in clinical samples and sensitivity testing along with reinforcement of standard infection control measures are essential to reduce outbreaks.

CONCLUSION

The clinicians working in the ICUs need to be aware of this kind of rare organism as a potential pathogen especially in infants undergoing surgery for complex congenital heart disease with a protracted postoperative course. Also risk factors like ECMO, longer mechanical ventilation, PD, invasive lines and sepsis caused by multidrug resistant Gram-negative bacteria, exposure to broad spectrum antibiotics, etc. should warrant prompt initiation of therapy along with strict reinforcement of standard infection control measures.

Footnotes

Source of support: Nil

Conflict of interest: None

REFERENCES

  • 1.King EO. “Studies on a group of previously unclassified bacteria associated with meningitis in infants,”. American Journal of Clinical Pathology. 1959;;31::241-–247.. doi: 10.1093/ajcp/31.3.241. [DOI] [PubMed] [Google Scholar]
  • 2.Ceyhan M,, Celik M. Elizabethkingia meningosepticum (Chryseobacterium meningosepticum) Infections in Children. Int J Pediatr. 2011;:215-237.. doi: 10.1155/2011/215237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Chiu CH,, Waddingdon M, et al. “Atypical Chryseobacterium men-ingosepticum and meningitis and sepsis in newborns and the immunocompromised, Taiwan,”. Emerging Infectious Diseases. 2000;;6((5):):481-–486.. doi: 10.3201/eid0605.000506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Hoque SN,, Graham J, et al. “Chryseobacterium (Flavobacterium) meningosepticum outbreak associated with colonization of water taps in a neonatal intensive care unit,”. Journal of Hospital Infection. 2001;;47((3):):188-–192.. doi: 10.1053/jhin.2000.0908. [DOI] [PubMed] [Google Scholar]
  • 5.Nulens E,, Bussels B, et al. “Recurrent bacteremia by Chryseobacterium indologenes in an oncology patient with a totally implanted intravenous device,”. Clinical Microbiology and Infection. 2001;;7((7);):391-393.. doi: 10.1046/j.1198-743x.2001.00273.x. [DOI] [PubMed] [Google Scholar]
  • 6.Lin PY,, Chu C, et al. Microbiological Analysis of Bloodstream Infections Caused by Chryseobacterium meningosepticum in Nonneonatal Patients. J Clin Microbiol. 2004;;42::3353-–3355.. doi: 10.1128/JCM.42.7.3353-3355.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Kirby JT,, Sader HS, et al. Antimicrobial Susceptibility and Epidemiology of a Worldwide Collection of Chryseobacterium spp.: Report from the SENTRY Antimicrobial Surveillance Program (1997-2001) J Clin Microbiol. 2004;;42::445-–448.. doi: 10.1128/JCM.42.1.445-448.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Pereira GH,, de Oliveira Garcia D, et al. Nosocomial infections caused by Elizabethkingia Meningoseptica: An emerging pathogen. Braz J Infec Dis. 2013;;17::606-–609.. doi: 10.1016/j.bjid.2013.02.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Güngör S,, Özen M, et al. “A Chryseobacteriummeningosepticum outbreak in a neonatal ward,”. Infection Control and Hospital Epidemiology. 2003;;24((8):):613-–617.. doi: 10.1086/502261. [DOI] [PubMed] [Google Scholar]
  • 10.Ratner H. “Flavobacteriummeningosepticum,”. Infection Control. 1984;;5((5)):237-–239.. [PubMed] [Google Scholar]
  • 11.Fraser SL,, Jorgensen JH. “Reappraisalof the antimicrobial susceptibilities of Chryseobacterium and Flavobacterium species and methods for reliable susceptibility testing,”. Antimicrobial Agents and Chemotherapy. 1997;;12::2738-–2741.. doi: 10.1128/aac.41.12.2738. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Govindaswamy A,, Bajpai V,, Trikha V,, Mittal S,, Malhotra R,, Mathur P. Multidrug resistant Elizabethkingia meningoseptica bacteremia-Experience from a level 1 trauma centre in India. Intractable Rare Dis Res. 2018;;7((3):):172-–176.. doi: 10.5582/irdr.2018.01077. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Indian Journal of Critical Care Medicine : Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine are provided here courtesy of Indian Society of Critical Care Medicine

RESOURCES